MOHRUS TAPE L is a modern transdermal patch impregnated with the non-steroidal anti-inflammatory drug (NSAID) ketoprofen at a dose of 40 mg per unit. A pack of 70 patches is designed for a long-term therapeutic course and is popular among patients with chronic joint and spinal conditions, as well as athletes seeking localized pain relief without systemic burden on the body.
The key advantage of MOHRUS TAPE L over oral NSAID formulations lies in its active-substance delivery method. Ketoprofen, penetrating the skin directly to the pain source, builds a therapeutic concentration precisely within the target zone — the affected joint, inflamed muscle, or injured ligament. Meanwhile, the concentration of the drug in the systemic bloodstream remains minimal. This yields two important consequences:
Ketoprofen, belonging to the propionic acid derivative group, inhibits the activity of cyclooxygenase (COX-1 and COX-2), interrupting the cascade of prostaglandin synthesis — the mediators of inflammation, pain, and fever. The result: edema reduction, pain relief, and restoration of mobility in the affected region.
The drug is recommended for local symptomatic treatment in the following conditions:
Absolute prohibitions for MOHRUS TAPE L use:
Most side effects are confined to the application site:
If persistent irritation develops, the rash spreads beyond the application zone, or systemic symptoms appear, the patch should be removed and a physician consulted.
